Phase 2 Chronic Hepatitis D Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus

Chronic Hepatitis Delta

Gilead Sciences107 enrolled15 locationsNCT07096193

Recruiting

Phase 2Phase 3

Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide

Chronic Hepatitis D

Mirum Pharmaceuticals, Inc.120 enrolled22 locationsNCT07454837

Recruiting

Phase 2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BJT-778 in Subjects with Chronic HBV Infection (CHB) and Chronic HDV Infection (CHD).

Chronic Hepatitis D Virus (HDV) InfectionChronic Hepatitis B Virus (HBV) Infection

Bluejay Therapeutics Inc.72 enrolled9 locationsACTRN12623000105640